Table 1.
Summary of results
| Status | Patient (n) | Median survival (months) | 5-year survival | P-value (Mantel-Cox) |
|---|---|---|---|---|
| N2/ApN+ | 18 | 24 | 11% | – |
| N2/ApN− | 43 | 37 | 49% | 0.02 |
| M+ | 30 | 16 | 6% | 0.17 |
Compared to survival for N2/ApN+ patients (Mantel-Cox).
Summary of results
| Status | Patient (n) | Median survival (months) | 5-year survival | P-value (Mantel-Cox) |
|---|---|---|---|---|
| N2/ApN+ | 18 | 24 | 11% | – |
| N2/ApN− | 43 | 37 | 49% | 0.02 |
| M+ | 30 | 16 | 6% | 0.17 |
Compared to survival for N2/ApN+ patients (Mantel-Cox).